Jasper Therapeutics Inc. (JSPR)

3.68

-0.33 (-8.23%)

At close: Apr 04, 2025, 10:42 AM

Jasper Therapeutics Cash Flow Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-71.27M	-64.47M	-37.69M	-30.64M	-31.67M	-4.99M
Depreciation & Amortization	1.37M	1.11M	975K	377K	21K	n/a
Stock-Based Compensation	6.62M	5.21M	4.09M	1.05M	1.21M	6K
Other Working Capital	295K	2.06M	1.5M	-1.32M	938K	1.39M
Other Non-Cash Items	502K	976K	-12.59M	-9.09M	10.9M	1.62M
Deferred Income Tax	n/a	n/a	n/a	3M	-21K	n/a
Change in Working Capital	173K	5.1M	-649K	1.62M	1.3M	1.39M
Operating Cash Flow	-62.6M	-52.07M	-45.86M	-33.68M	-18.27M	-1.97M
Capital Expenditures	-552K	-267K	-576K	-2.43M	n/a	n/a
Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	20K	n/a	n/a	n/a	198.34K	n/a
Investing Cash Flow	-532K	-267K	-576K	-2.43M	198.34K	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	1.5M
Common Stock Repurchased	n/a	n/a	28K	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	689K	-508K	55K	90.22M	53K	27.63M
Financial Cash Flow	47.88M	100.97M	55K	100.97M	11.29M	29.13M
Net Cash Flow	-15.25M	48.64M	-46.38M	64.86M	-6.98M	27.16M
Free Cash Flow	-63.15M	-52.33M	-46.43M	-36.11M	-18.27M	-1.97M